The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population
Open accessAbstract
Purpose: The aim of this study was to estimate the contribution of deleterious mutations in the RAD51B, RAD51C, and RAD51D genes to invasive epithelial ovarian cancer (EOC) in the population and in a screening trial of individuals at high risk of ovarian cancer. Patients and Methods: The coding sequence and splice site boundaries of the three RAD51 genes were sequenced and analyzed in germline DNA from a case-control study of 3,429 patients with invasive EOC and 2,772 controls as well as in 2,000 unaffected women who were BRCA1/BRCA2 negative from the United Kingdom Familial Ovarian Cancer Screening Study (UK_FOCSS) after quality-control analysis. Results: In the case-control study, we identified predicted deleterious mutations in 28 EOC cases (0.82%) compared with three controls (0.11%; P < .001). Mutations in EOC cases were more frequent in RAD51C (14 occurrences, 0.41%) and RAD51D (12 occurrences, 0.35%) than in RAD51B (two occurrences, 0.06%). RAD51C mutations were associated with an odds ratio of 5.2 (95% CI, 1.1 to 24; P = .035), and RAD51D mutations conferred an odds ratio of 12 (95% CI, 1.5 to 90; P = .019). We identified 13 RAD51 mutations (0.65%) in unaffected UK_FOCSS participants (RAD51C, n = 7; RAD51D, n = 5; and RAD51B, n = 1), which was a significantly greater rate than in controls (P < .001); furthermore, RAD51 mutation carriers were more likely than noncarriers to have a family history of ovarian cancer (P < .001). Conclusion: These results confirm that RAD51C and RAD51D are moderate ovarian cancer susceptibility genes and suggest that they confer levels of risk of EOC that may warrant their use alongside BRCA1 and BRCA2 in routine clinical genetic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Predicting the Functional Effect of Amino Acid Substitutions and Indels
Choi, Y., Sims, G. E., Murphy, S., Miller, J. R., & Chan, A. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046688 · Cited by 2,890
SIFT web server: predicting effects of amino acid substitutions on proteins
Sim, N.-L., Kumar, P., Hu, J., Henikoff, S., Schneider, G., & Ng, P. C. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks539 · Cited by 2,411
Pennington, K. P., Walsh, T., Harrell, M. I., Lee, M. K., Pennil, C. C., Rendi, M. H., Thornton, A., Norquist, B. M., Casadei, S., Nord, A. S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2287 · Cited by 1,051
Walsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A. M., Roeb, W., Agnew, K. J., Stray, S. M., Wickramanayake, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115052108 · Cited by 933
Meindl, A., Hellebrand, H., Wiek, C., Erven, V., Wappenschmidt, B., Niederacher, D., Freund, M., Lichtner, P., Hartmann, L., Schaal, H., et al. (2010) · Nature Genetics · doi:10.1038/ng.569 · Cited by 743
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (UK), Loveday, C., Turnbull, C., Ramsay, E., Hughes, D., Ruark, E., Frankum, J. R., Bowden, G., Kalmyrzaev, B., Warren-Perry, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.893 · Cited by 534
Study, A. C., Bojesen, S. E., Study, A. O. C., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), (GENICA), G. E. I. A. B. C., (SWE-BRCA), S. B. C. S., The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), (EMBRACE), E. S. O. B. &. B. M. C., (GEMO), G. M. O. C. R. I. B. M. C., Pooley, K. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2566 · Cited by 528
Self-citationThe BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
Antoniou, A. C., Cunningham, A. P., Peto, J., Evans, D. G., Lalloo, F., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Southey, M. C., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604305 · Cited by 525
Self-citationVariation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
Mutations in BRIP1 confer high risk of ovarian cancer
Rafnar, T., Gudbjartsson, D. F., Sulem, P., Jonasdottir, A., Sigurdsson, A., Jonasdottir, A., Besenbacher, S., Lundin, P., Stacey, S. N., Gudmundsson, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.955 · Cited by 406
Couch, F. J., Wang, X., McGuffog, L., Lee, A., Olswold, C., Kuchenbaecker, K. B., Soucy, P., Fredericksen, Z., Barrowdale, D., Dennis, J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003212 · Cited by 371
Self-citationGWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Study, A. C., Pharoah, P. D. P., Australian Ovarian Cancer Study Group, Tsai, Y.-Y., Ramus, S. J., Phelan, C. M., Goode, E. L., Lawrenson, K., Buckley, M., Fridley, B. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2564 · Cited by 351
Self-citationA genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
The Wellcome Trust Case-Control Consortium, Goode, E. L., Cancer), T. A. C. S. (., The Australian Ovarian Cancer Study Group, the Ovarian Cancer Association Consortium (OCAC), Chenevix-Trench, G., Song, H., Ramus, S. J., Notaridou, M., Lawrenson, K., et al. (2010) · Nature Genetics · doi:10.1038/ng.668 · Cited by 344
Self-citationA genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2
Study, A. C. (., Song, H., The Australian Ovarian Cancer Study Group, The Ovarian Cancer Association Consortium, Ramus, S. J., Tyrer, J., Bolton, K. L., Gentry-Maharaj, A., Wozniak, E., Anton-Culver, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.424 · Cited by 313
Self-citationGermline RAD51C mutations confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (BCSC) (UK), Loveday, C., Turnbull, C., Ruark, E., Xicola, R. M. M., Ramsay, E., Hughes, D., Warren-Perry, M., Snape, K., Eccles, D., et al. (2012) · Nature Genetics · doi:10.1038/ng.2224 · Cited by 252
Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers
Lakhani, S. R., Manek, S., Penault-Llorca, F., Flanagan, A., Arnout, L., Merrett, S., McGuffog, L., Steele, D., Devilee, P., Klijn, J. G. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1029-3 · Cited by 252
Self-citationCommon variants at 19p13 are associated with susceptibility to ovarian cancer
the Australian Ovarian Cancer Study Group, Bolton, K. L., Cancer), T. A. C. S. (., on behalf of the Ovarian Cancer Association Consortium, Tyrer, J., Song, H., Ramus, S. J., Notaridou, M., Jones, C., Sher, T., et al. (2010) · Nature Genetics · doi:10.1038/ng.666 · Cited by 246
Self-citationA systematic review and meta‐analysis of family history and risk of ovarian cancer
Stratton, J. F., Pharoah, P., Smith, S. K., Easton, D., & Ponder, B. A. J. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10148.x · Cited by 239
Self-citationVariation in BRCA1 cancer risks by mutation position.
Thompson, D. J., & Easton, D. F. (2002) · PubMed · Cited by 187
Eng, L., Coutinho, G., Nahas, S., Yeo, G., Tanouye, R., Babaei, M., Dörk, T., Burge, C., & Gatti, R. A. (2004) · Human Mutation · doi:10.1002/humu.10295 · Cited by 160
Shen, H., Fridley, B. L., Song, H., Lawrenson, K., Cunningham, J. M., Ramus, S. J., Cicek, M. S., Tyrer, J., Stram, D., Larson, M. C., et al. (2013) · Nature Communications · doi:10.1038/ncomms2629 · Cited by 160
Self-citationSong, H., Cicek, M. S., Dicks, E., Harrington, P. A., Ramus, S. J., Cunningham, J. M., Fridley, B. L., Tyrer, J. P., Alsop, J., Jimenez‐Liñan, M., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu172 · Cited by 158
Self-citationRosenthal, A. N., Fraser, L. S. M., Manchanda, R., Badman, P. D., Philpott, S., Mozersky, J. T., Hadwin, R. J., Cafferty, F. H., Benjamin, E. O., Singh, N., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7638 · Cited by 156
Self-citationRAD51C is a susceptibility gene for ovarian cancer
Pelttari, L. M., Heikkinen, T., Thompson, D. J., Kallioniemi, A. H., Schleutker, J., Holli, K., BLOMQVIST, C. P., Aittomäki, K., Bützow, R. C., & Nevanlinna, H. A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr229 · Cited by 142
Permuth‐Wey, J., Lawrenson, K., Shen, H. C., Velkova, A., Tyrer, J. P., Chen, Z., Lin, H., Chen, Y. A., Tsai, Y.-Y., Qu, X., et al. (2013) · Nature Communications · doi:10.1038/ncomms2613 · Cited by 113
Self-citationSøgaard, M., Kjær, S. K., Cox, M. J., Woźniak, E. L., Høgdall, E. V. S., Høgdall, C. K., Blaakær, J., Jacobs, I. J., Gayther, S. A., & Ramus, S. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4806 · Cited by 105
Self-citationOsório, A., Endt, D., Fernández, F., Eirich, K., de la Hoya, M., Schmutzler, R. K., Caldés, T., Meindl, A., Schindler, D., & Benitez, J. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds115 · Cited by 99
Risk Prediction Models For Familial Breast Cancer
Antoniou, A. C., & Easton, D. F. (2006) · Future Oncology · doi:10.2217/14796694.2.2.257 · Cited by 93
Jervis, S., Song, H., Lee, A., Dicks, E., Tyrer, J. P., Harrington, P. A., Easton, D. F., Jacobs, I. J., Pharoah, P. D. P., & Antoniou, A. C. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102015 · Cited by 93
Self-citationDomain mapping of the Rad51 paralog protein complexes
Miller, K. A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkg925 · Cited by 92
Thompson, E. R., Boyle, S. E., Johnson, J., Ryland, G. L., Sawyer, S. D., Choong, D. Y. H., kConFab, Chenevix‐Trench, G., Trainer, A. H., Lindeman, G. J., et al. (2011) · Human Mutation · doi:10.1002/humu.21625 · Cited by 84
Gayther, S. A., Harrington, P. A., Russell, P. A., Kharkevich, G., Гарькавцева, Р. Ф., & Ponder, B. A. J. (1996) · PubMed Central · Cited by 78
Self-citationChen, K., Ma, H., Li, J., Zang, R., Wang, C., Song, F., Shi, T., Yu, D., Yang, M., Xue, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms5682 · Cited by 77
Vuorela, M., Pylkäs, K., Hartikainen, J. M., Sundfeldt, K., Lindblom, A., von Wachenfeldt, A., Haanpää, M. K., Puistola, U., Rosengren, A., Anttila, M., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1677-x · Cited by 60
Thompson, E. R., Rowley, S. M., Sawyer, S. D., kConFab, Eccles, D., Trainer, A. H., Mitchell, G., James, P. A., & Campbell, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054772 · Cited by 42
Tyrer, J. P., Guo, Q., Easton, D. F., & Pharoah, P. D. P. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-177 · Cited by 16
Self-citation
Research works printed but not linked: 3
- Gayther SA, 1996, Am J Hum Genet, 58, 451
- 10.1016/j.ygyno.2012.09.009 · doi:10.1016/j.ygyno.2012.09.009
- Thompson D, 2002, Cancer Epidemiol Biomarkers Prev, 11, 329
Cited by
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Epidemiology of ovarian cancer: a review
Brett M., R., Brett M., R., Jennifer B., P., Thomas A., S., Jennifer B., P., & Thomas A., S. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,524
Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
Breast Cancer Association Consortium (2021) · New England Journal of Medicine · doi:10.1056/nejmoa1913948 · Cited by 1,136
Epidemiology of epithelial ovarian cancer
Webb, P. M., & Jordan, S. J. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.08.006 · Cited by 995
Inherited Mutations in Women With Ovarian Carcinoma
Norquist, B. M., Harrell, M. I., Brady, M. F., Walsh, T., Lee, M. K., Gulsuner, S., Bernards, S. S., Casadei, S., Yi, Q., Burger, R. A., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5495 · Cited by 769
Metadata
- Authors
- Song, H., Dicks, E., Ramus, S. J., Tyrer, J. P., Intermaggio, M. P., Hayward, J., Edlund, C. K., Conti, D., Harrington, P., Fraser, L., Philpott, S., Anderson, C., Rosenthal, A., Gentry-Maharaj, A., Bowtell, D. D., Alsop, K., Cicek, M. S., Cunningham, J. M., Fridley, B. L., Alsop, J., Jimenez-Linan, M., Høgdall, E., Høgdall, C. K., Jensen, A., Kjaer, S. K., Lubiński, J., Huzarski, T., Jakubowska, A., Gronwald, J., Poblete, S., Lele, S., Sucheston-Campbell, L., Moysich, K. B., Odunsi, K., Goode, E. L., Menon, U., Jacobs, I. J., Gayther, S. A., & Pharoah, P. D. P.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-09-10
- Volume
- 33
- Issue
- 26
- Pages
- 2901-2907
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2153966196
- Cited by
- 328
- References
- 44
- FWCI
- 21.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.